JACQUELINE ANDERS: Open Payments
NPI 1881075877 · NORTH WEBSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 33 payments from 12 companies in 2025. Trend: 2023 $607 · 2024 $539 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $209 |
| Otsuka America Pharmaceutical, Inc. | 6 | $197 |
| ABBVIE INC. | 5 | $99 |
| Organon LLC | 1 | $81 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Lilly USA, LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Auvelity, REXULTI, VRAYLAR, JADA SYSTEM, KEVEYIS, CAPLYTA, JARDIANCE, FANAPT.
Industry payments across IN — which companies pay providers there.
